A Bayesian Approach to in Silico Blood-Brain Barrier Penetration Modeling
- 6 June 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 52 (6), 1686-1697
- https://doi.org/10.1021/ci300124c
Abstract
The human blood-brain barrier (BBB) is a membrane that protects the central nervous system (CNS) by restricting the passage of solutes. The development of any new drug must take into account its existence whether for designing new molecules that target components of the CNS or, on the other hand, to find new substances that should not penetrate the barrier. Several studies in the literature have attempted to predict BBB penetration, so far with limited success and few, if any, application to real world drug discovery and development programs. Part of the reason is due to the fact that only about 2% of small molecules can cross the BBB, and the available data sets are not representative of that reality, being generally biased with an over-representation of molecules that show an ability to permeate the BBB (BBB positives). To circumvent this limitation, the current study aims to devise and use a new approach based on Bayesian statistics, coupled with state-of-the-art machine learning methods to produce a robust model capable of being applied in real-world drug research scenarios. The data set used, gathered from the literature, totals 1970 curated molecules, one of the largest for similar studies. Random Forests and Support Vector Machines were tested in various configurations against several chemical descriptor set combinations. Models were tested in a 5-fold cross-validation process, and the best one tested over an independent validation set. The best fitted model produced an overall accuracy of 95%, with a mean square contingency coefficient (ϕ) of 0.74, and showing an overall capacity for predicting BBB positives of 83% and 96% for determining BBB negatives. This model was adapted into a Web based tool made available for the whole community at http://b3pp.lasige.di.fc.ul.pt.Keywords
This publication has 38 references indexed in Scilit:
- A novel hypothesis of blood-brain barrier (BBB) development and in vitro BBB model: neural stem cell is the driver of BBB formation and maintenanceJournal of Experimental and Integrative Medicine, 2012
- A turning point for blood-brain barrier modeling.Pharmaceutical Research, 2009
- Characteristics of compounds that cross the blood-brain barrierBMC Neurology, 2009
- QSAR Modeling of the Blood–Brain Barrier Permeability for Diverse Organic CompoundsPharmaceutical Research, 2008
- Predicting Penetration Across the Blood-Brain Barrier from Simple Descriptors and Fragmentation SchemesJournal of Chemical Information and Modeling, 2006
- In Silico Predictions of Blood-Brain Barrier Penetration: Considerations to “Keep in Mind”Journal of Pharmacology and Experimental Therapeutics, 2005
- The blood-brain barrier: Bottleneck in brain drug developmentNeuroRX, 2005
- High throughput artificial membrane permeability assay for blood–brain barrierEuropean Journal of Medicinal Chemistry, 2003
- A simple model to predict blood–brain barrier permeation from 3D molecular fieldsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2002
- Introduction to the Blood-Brain BarrierPublished by Cambridge University Press (CUP) ,1998